How Tirzepatide Works (Dual GIP/GLP-1 Agonist) Tirzepatide mimics two peptide hormones: GLP-1 and GIP
Pharmacokinetic Highlights Half-life of roughly five days , allowing steady plasma levels Peak concentration reached within 872 hours after injection Slow enzymatic breakdown , reducing the likelihood of drug interactions Pharmacodynamic Effects Dose-dependent reductions in fasting and postprandial glucose Better beta-cell responsiveness and glucose balance Progressive HbA1c and weight reductions as the dose increases Low hypoglycemia risk when used alone Clinical Development, Approval History, and Indication Context of Mounjaro (Tirzepatide) Mounjaro , the brand name for tirzepatide , was approved by the U.S
That said, blood pressure spikes can happen for a range of reasons, including stress, pain, smoking, or interactions with other medications
Risks to the Pancreas Both medications carry a small risk of pancreatitis, which is inflammation of the pancreas